Polynovo Limited Stock Net Income
| CALZF Stock | USD 0.70 0.00 0.00% |
As of the 16th of February 2026, PolyNovo holds the Variance of 9.4, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,233). PolyNovo Limited technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check PolyNovo Limited standard deviation and value at risk to decide if PolyNovo Limited is priced some-what accurately, providing market reflects its current price of 0.7 per share. As PolyNovo Limited is a penny stock we also suggest to check out its jensen alpha numbers.
PolyNovo's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PolyNovo's valuation are provided below:PolyNovo Limited does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. PolyNovo |
PolyNovo 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PolyNovo's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PolyNovo.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in PolyNovo on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding PolyNovo Limited or generate 0.0% return on investment in PolyNovo over 90 days. PolyNovo is related to or competes with Sanofi, CSL, GSK Plc, Fresenius, Sonova Holding, Essilor International, and EssilorLuxottica. PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Sin... More
PolyNovo Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PolyNovo's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PolyNovo Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 22.71 | |||
| Value At Risk | (6.02) | |||
| Potential Upside | 5.13 |
PolyNovo Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PolyNovo's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PolyNovo's standard deviation. In reality, there are many statistical measures that can use PolyNovo historical prices to predict the future PolyNovo's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.17) |
PolyNovo February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 1.29 | |||
| Coefficient Of Variation | (2,233) | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.4 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 22.71 | |||
| Value At Risk | (6.02) | |||
| Potential Upside | 5.13 | |||
| Skewness | 0.809 | |||
| Kurtosis | 7.46 |
PolyNovo Limited Backtested Returns
PolyNovo Limited maintains Sharpe Ratio (i.e., Efficiency) of -0.021, which implies the firm had a -0.021 % return per unit of risk over the last 3 months. PolyNovo Limited exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PolyNovo's Coefficient Of Variation of (2,233), risk adjusted performance of (0.03), and Variance of 9.4 to confirm the risk estimate we provide. The company holds a Beta of 0.85, which implies possible diversification benefits within a given portfolio. PolyNovo returns are very sensitive to returns on the market. As the market goes up or down, PolyNovo is expected to follow. At this point, PolyNovo Limited has a negative expected return of -0.0655%. Please make sure to check PolyNovo's standard deviation, value at risk, as well as the relationship between the Value At Risk and day median price , to decide if PolyNovo Limited performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.12 |
Insignificant reverse predictability
PolyNovo Limited has insignificant reverse predictability. Overlapping area represents the amount of predictability between PolyNovo time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PolyNovo Limited price movement. The serial correlation of -0.12 indicates that less than 12.0% of current PolyNovo price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | -0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, PolyNovo Limited reported net income of (1.19 Million). This is 100.35% lower than that of the Healthcare sector and 100.5% lower than that of the Medical Devices industry. The net income for all United States stocks is 100.21% higher than that of the company.
PolyNovo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PolyNovo's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PolyNovo could also be used in its relative valuation, which is a method of valuing PolyNovo by comparing valuation metrics of similar companies.PolyNovo is currently under evaluation in net income category among its peers.
PolyNovo Fundamentals
| Return On Equity | -0.0595 | |||
| Return On Asset | 0.0092 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 954.45 M | |||
| Shares Outstanding | 688 M | |||
| Shares Owned By Insiders | 16.72 % | |||
| Shares Owned By Institutions | 16.10 % | |||
| Price To Book | 79.32 X | |||
| Price To Sales | 26.17 X | |||
| Revenue | 41.44 M | |||
| Gross Profit | 33.94 M | |||
| EBITDA | 753.46 K | |||
| Net Income | (1.19 M) | |||
| Cash And Equivalents | 6.15 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.8 M | |||
| Debt To Equity | 0.62 % | |||
| Current Ratio | 2.09 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (2.06 M) | |||
| Number Of Employees | 152 | |||
| Beta | 1.47 | |||
| Market Capitalization | 1.04 B | |||
| Total Asset | 34.97 M | |||
| Retained Earnings | (92 M) | |||
| Working Capital | 11 M | |||
| Current Asset | 12 M | |||
| Current Liabilities | 1000 K | |||
| Net Asset | 34.97 M |
About PolyNovo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PolyNovo Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PolyNovo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PolyNovo Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in PolyNovo Pink Sheet
PolyNovo financial ratios help investors to determine whether PolyNovo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PolyNovo with respect to the benefits of owning PolyNovo security.